We have demonstrated that elevated levels of urinary HAI-1 and EpCAM are associated with BC-specific mortality in high-risk NMIBC patients: each biomarker is associated with increased risk of death from disease within 5-years (adjusted for EAU risk group). This evidence concerns the gene EPCAM and breast cancer.